- Home
- MRAM vs RPTX Comparison
MRAM vs RPTX Comparison
Compare MRAM & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRAM
- RPTX
- Stock Information
- Founded
- MRAM 2008
- RPTX 2016
- Country
- MRAM United States
- RPTX Canada
- Employees
- MRAM N/A
- RPTX N/A
- Industry
- MRAM Semiconductors
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- MRAM Technology
- RPTX Health Care
- Exchange
- MRAM Nasdaq
- RPTX Nasdaq
- Market Cap
- MRAM 137.3M
- RPTX 119.7M
- IPO Year
- MRAM 2016
- RPTX 2020
- Fundamental
- Price
- MRAM $6.35
- RPTX $3.14
- Analyst Decision
- MRAM Strong Buy
- RPTX Strong Buy
- Analyst Count
- MRAM 2
- RPTX 2
- Target Price
- MRAM $9.00
- RPTX $17.50
- AVG Volume (30 Days)
- MRAM 102.9K
- RPTX 137.2K
- Earning Date
- MRAM 10-30-2024
- RPTX 11-07-2024
- Dividend Yield
- MRAM N/A
- RPTX N/A
- EPS Growth
- MRAM N/A
- RPTX N/A
- EPS
- MRAM 0.07
- RPTX N/A
- Revenue
- MRAM $58,238,000.00
- RPTX $68,683,000.00
- Revenue This Year
- MRAM N/A
- RPTX $16.85
- Revenue Next Year
- MRAM $8.94
- RPTX N/A
- P/E Ratio
- MRAM $86.17
- RPTX N/A
- Revenue Growth
- MRAM N/A
- RPTX N/A
- 52 Week Low
- MRAM $4.89
- RPTX $2.71
- 52 Week High
- MRAM $10.50
- RPTX $8.49
- Technical
- Relative Strength Index (RSI)
- MRAM 65.53
- RPTX 42.87
- Support Level
- MRAM $5.76
- RPTX $3.37
- Resistance Level
- MRAM $6.01
- RPTX $3.52
- Average True Range (ATR)
- MRAM 0.21
- RPTX 0.20
- MACD
- MRAM 0.06
- RPTX -0.04
- Stochastic Oscillator
- MRAM 91.01
- RPTX 9.09
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA); and Asia-Pacific (APAC).
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.